RIM
ABMD

Rampart Investment Management’s Abiomed Inc ABMD Stock Holding History

Rampart Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-289
Closed -$80K – 384
2020
Q3 		$80K Sell
289
-550
-66% -$158K 0.05% 287
2020
Q2 		$203K Buy
839
+494
+143% +$99.2K 0.03% 379
2020
Q1 		$50K Sell
345
-441
-56% -$73.2K 0.02% 447
2019
Q4 		$134K Sell
786
-15
-2% -$2.78K 0.02% 496
2019
Q3 		$142K Sell
801
-40
-5% -$8.65K 0.02% 473
2019
Q2 		$219K Sell
841
-57
-6% -$15.1K 0.03% 438
2019
Q1 		$256K Buy
898
+425
+90% +$141K 0.03% 414
2018
Q4 		$154K Buy
+473
New +$164K 0.04% 312
2018
Q3 		– Sell
-427
Closed -$175K – 539
2018
Q2 		$175K Buy
+427
New +$155K 0.02% 460

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Rampart Investment Management's ABMD Position: Q4 2020 in Review

Rampart Investment Management sold out of Abiomed Inc (ABMD) in Q4 2020, closing a stake of 289 shares — an estimated $80K sold.

Rampart Investment Management first reported a position in ABMD in Q2 2018 and held it in 9 quarters. The position peaked at $256K in Q1 2019. 498 funds tracked by Wall St. Rank hold ABMD as of Q4 2020.

  • Rampart Investment Management reported no remaining Abiomed Inc position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 289 Abiomed Inc shares in Q4 2020, an estimated $80K.
  • Rampart Investment Management first reported a position in Abiomed Inc in Q2 2018 and held it in 9 quarters.
  • Rampart Investment Management's Abiomed Inc position peaked at $256K in Q1 2019.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.